-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanexa and Novo Nordisk have reached a global licensing and cooperation agreement worth €1,165 billion for long-acting injections.

智通财经·09/25/2026 12:09:19
语音播报
Nanexa and Novo Nordisk have reached a global licensing and cooperation agreement worth €1,165 billion for long-acting injections.